Fish oil-containing emulsions: When fat seems to improve clinical outcomes in the critically ill

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 3, 2016, Pages 305-307

  Manzanares, William ^a   Langlois, Pascal L ^b   Lemieux, Margot ^c   Heyland, Daren K ^c,d  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

critically ill; fish oil; infections; lipid emulsions; parenteral nutrition

Indexed keywords

FISH OIL; LIPID EMULSION;

ACUTE PANCREATITIS; ADULT RESPIRATORY DISTRESS SYNDROME; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CRITICALLY ILL PATIENT; HEART ARRHYTHMIA; HEART PROTECTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK REDUCTION; SEPSIS; CHEMISTRY; CRITICAL ILLNESS; LENGTH OF STAY; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC);

CRITICAL ILLNESS; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; META-ANALYSIS AS TOPIC; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84959301154     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115586263     Document Type: Review

References (11)

1. Teitelbaum DH, Guenter P, Griebel D, et al. Proceedings from FDA/A.S.P.E.N. public workshop: clinical trial design for intravenous fat emulsion products, October 29, 2013 [published online 4, 2014 ]. JPEN J Parenter Enteral Nutr.
2. Heller AR,. Intravenous fish oil in adult intensive care unit patients. World Rev Nutr Diet. 2015; 112: 127-140.
3. Manzanares W, Dhaliwal R, Jurewitsch B, et al. Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr. 2014; 38: 20-28.
4. Grau-Carmona T, Bonet-Saris A, García-de-Lorenzo A, et al. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU Lipids Study. Crit Care Med. 2015; 43: 32-39.
5. Gultekin G, Sahin H, Inanc N, Uyanik F, Ok E,. Impact of omega-3 and omega-9 fatty acids enriched total parenteral nutrition on blood chemistry and inflammatory markers in septic patients. Pak J Med Sci. 2014; 30: 299-304.
6. Hall TC, Bilku DK, Al-Leswas D, et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically Ill patients with sepsis: a pilot study. JPEN J Parenter Enteral Nutr. 2015; 39 (3): 301-312.
7. Burkhart CS, Dell-Kuster S, Siegemund M, et al. Effect of n-3 fatty acids on markers of brain injury and incidence of sepsis associated delirium in septic patients. Acta Anaesthesiol Scand. 2014; 58: 689-700.
8. Manzanares W, Langlois P.L, Dhaliwal R, Lemieux M, Heyland DK,. Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis. Crit Care 2015; 19: 167. http://ccforum.com/content/19/1/167. Accessed April 28, 2015.
9. 2015 Canadian Clinical Practice Guidelines. www.criticalcarenutrition.com. Accessed April 25, 2015.
10. Berger MM, Delodder F, Liaudet L, et al. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr. 2013; 97: 246-254.
11. Heidt MC, Vician M, Stracke SK, et al. Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg. 2009; 57: 276-280.